NovaBay Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 2519%.

Top 23 shareholders own 2.68% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
0.88%	C2C Wealth Management, LLC	42,948	US$30.9k	0%	0.03%
0.54%	Geode Capital Management, LLC	26,337	US$19.0k	3,580%	no data
0.43%	UBS Asset Management AG	21,062	US$15.2k	158%	no data
0.4%	Virtu Financial LLC, Asset Management Arm	19,590	US$14.1k	0%	no data
0.2%	Warberg Asset Management LLC	10,000	US$7.2k	0%	0.03%
0.11%	Tower Research Capital Europe Limited	5,481	US$3.9k	66.4%	no data
0.087%	Tian Tian Limited	4,235	US$3.0k	0%	no data
0.01%	Morgan Stanley, Investment Banking and Brokerage Investments	503	US$362.2	16,700%	no data
0.008%	The Vanguard Group, Inc.	391	US$281.3	0%	no data
0.0016%	Paul Freiman	77	US$55.6	0%	no data
0.0015%	Yenyou Zheng	75	US$54.2	0%	no data
0.0015%	Mijia Wu	75	US$54.2	0%	no data
0.0015%	Swan Sit	75	US$54.2	0%	no data
0.0014%	Justin Hall	68	US$48.9	0%	no data
0.001%	Julie Garlikov	50	US$35.9	0%	no data
0.001%	Yongxiang Zheng	50	US$35.9	0%	no data
0.00086%	Bank of America Corporation, Asset Management Arm	42	US$30.2	0%	no data
0.00006%	NVWM LLC	3	US$2.1	0%	no data
0.00004%	Thrivent Trust Company, Asset Management Arm	2	US$1.4	-94.6%	no data
0.00002%	RBC Dominion Securities Inc., Asset Management Arm	1	US$0.7	0%	no data
0.00002%	Securities America Advisors, Inc.	1	US$0.7	0%	no data
0.00002%	Northwestern Mutual Wealth Management Company	1	US$0.7	0%	no data
0.00002%	Addison Advisors LLC	1	US$0.7	0%	no data